Targeted Genomics

Targeted Genomics is a California-based biotechnology research company specializing in targeted DNA testing solutions for root causes of disease and response to therapy.

We develop and offer the GlutenID™ test, an FDA 510(k) cleared at-home celiac genetic risk test, empowering individuals and families to understand their risk.

Targeted Genomics leverages proprietary next-generation sequencing (NGS) assays, designed for simplicity and reliability, and is committed to providing actionable insights for evidence-based decision-making and informed lifestyle choices. Our family-owned company, founded in 2014, combines medical expertise with a dedication to genomic knowledge sharing, fostering dialogue between customers, healthcare providers, and loved ones.

Dr. Shelly Gunn, MD, PhD, serves as the company’s Medical Director, bringing years of experience in pathology and molecular diagnostics to ensure the accuracy and clinical relevance of our testing services. We partner with PacificDx, a CAP/CLIA certified laboratory, to maintain the highest standards of quality and privacy.